annual cash & cash equivalents:
$1.04B+$260.38M(+33.48%)Summary
- As of today (August 23, 2025), EXAS annual cash & cash equivalents is $1.04 billion, with the most recent change of +$260.38 million (+33.48%) on December 31, 2024.
- During the last 3 years, EXAS annual cash & cash equivalents has risen by +$7.55 million (+0.73%).
- EXAS annual cash & cash equivalents is now -43.59% below its all-time high of $1.84 billion, reached on December 31, 2020.
Performance
EXAS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$858.43M+$72.26M(+9.19%)Summary
- As of today (August 23, 2025), EXAS quarterly cash & cash equivalents is $858.43 million, with the most recent change of +$72.26 million (+9.19%) on June 30, 2025.
- Over the past year, EXAS quarterly cash & cash equivalents has dropped by -$88.35 million (-9.33%).
- EXAS quarterly cash & cash equivalents is now -53.35% below its all-time high of $1.84 billion, reached on December 31, 2020.
Performance
EXAS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EXAS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.5% | -9.3% |
| 3 y3 years | +0.7% | +17.9% |
| 5 y5 years | +220.7% | -29.8% |
EXAS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.2% | -17.3% | +35.8% |
| 5 y | 5-year | -43.6% | +220.7% | -53.4% | +35.8% |
| alltime | all time | -43.6% | >+9999.0% | -53.4% | >+9999.0% |
EXAS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $858.43M(+9.2%) |
| Mar 2025 | - | $786.17M(-24.3%) |
| Dec 2024 | $1.04B(+33.5%) | $1.04B(+1.7%) |
| Sep 2024 | - | $1.02B(+7.9%) |
| Jun 2024 | - | $946.78M(+45.2%) |
| Mar 2024 | - | $652.09M(-16.1%) |
| Dec 2023 | $777.64M(+23.0%) | $777.64M(+5.9%) |
| Sep 2023 | - | $734.41M(-5.3%) |
| Jun 2023 | - | $775.71M(+11.0%) |
| Mar 2023 | - | $698.65M(+10.5%) |
| Dec 2022 | $632.06M(-38.7%) | $632.06M(-5.5%) |
| Sep 2022 | - | $669.11M(-8.1%) |
| Jun 2022 | - | $728.04M(-10.9%) |
| Mar 2022 | - | $816.98M(-20.7%) |
| Dec 2021 | $1.03B(-44.0%) | $1.03B(-15.4%) |
| Sep 2021 | - | $1.22B(-6.8%) |
| Jun 2021 | - | $1.31B(-5.1%) |
| Mar 2021 | - | $1.38B(-25.1%) |
| Dec 2020 | $1.84B(+468.5%) | $1.84B(+43.4%) |
| Sep 2020 | - | $1.28B(+4.9%) |
| Jun 2020 | - | $1.22B(-0.7%) |
| Mar 2020 | - | $1.23B(+280.4%) |
| Dec 2019 | $323.65M(-71.2%) | $323.65M(-72.1%) |
| Sep 2019 | - | $1.16B(-6.4%) |
| Jun 2019 | - | $1.24B(-3.4%) |
| Mar 2019 | - | $1.28B(+14.1%) |
| Dec 2018 | $1.12B(+164.7%) | $1.12B(-5.1%) |
| Sep 2018 | - | $1.19B(-3.0%) |
| Jun 2018 | - | $1.22B(+17.3%) |
| Mar 2018 | - | $1.04B(+145.4%) |
| Dec 2017 | $424.71M(+36.5%) | $424.71M(-8.2%) |
| Sep 2017 | - | $462.52M(-4.5%) |
| Jun 2017 | - | $484.26M(+76.3%) |
| Mar 2017 | - | $274.67M(-11.7%) |
| Dec 2016 | $311.10M(+1.4%) | $311.10M(-7.9%) |
| Sep 2016 | - | $337.83M(+50.8%) |
| Jun 2016 | - | $224.08M(-14.7%) |
| Mar 2016 | - | $262.59M(-14.4%) |
| Dec 2015 | $306.88M(+8.5%) | $306.88M(-10.7%) |
| Sep 2015 | - | $343.51M(+62.9%) |
| Jun 2015 | - | $210.82M(-14.0%) |
| Mar 2015 | - | $245.15M(-13.3%) |
| Dec 2014 | $282.76M | $282.76M(+33.9%) |
| Sep 2014 | - | $211.14M(-10.1%) |
| Jun 2014 | - | $234.80M(+102.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $116.01M(-12.9%) |
| Dec 2013 | $133.26M(+23.2%) | $133.26M(-9.9%) |
| Sep 2013 | - | $147.84M(-6.3%) |
| Jun 2013 | - | $157.73M(+65.2%) |
| Mar 2013 | - | $95.48M(-11.7%) |
| Dec 2012 | $108.12M(+13.3%) | $108.12M(-8.8%) |
| Sep 2012 | - | $118.57M(+67.3%) |
| Jun 2012 | - | $70.86M(-15.2%) |
| Mar 2012 | - | $83.54M(-12.4%) |
| Dec 2010 | $95.42M(+284.3%) | $95.42M(+173.9%) |
| Sep 2010 | - | $34.84M(-7.9%) |
| Jun 2010 | - | $37.82M(+52.3%) |
| Dec 2009 | $24.83M(+97.3%) | $24.83M(-7.9%) |
| Sep 2009 | - | $26.94M(-3.1%) |
| Jun 2009 | - | $27.80M(+34.9%) |
| Mar 2009 | - | $20.61M(+239.6%) |
| Sep 2008 | - | $6.07M(-51.8%) |
| Dec 2007 | $12.59M(-40.3%) | $12.59M(-14.8%) |
| Sep 2007 | - | $14.78M(-12.8%) |
| Jun 2007 | - | $16.94M(-8.7%) |
| Mar 2007 | - | $18.56M(-11.9%) |
| Dec 2006 | $21.07M(-38.2%) | $21.07M(-13.5%) |
| Sep 2006 | - | $24.38M(-9.9%) |
| Jun 2006 | - | $27.04M(-9.2%) |
| Mar 2006 | - | $29.79M(-12.7%) |
| Dec 2005 | $34.12M(-32.1%) | $34.12M(-8.3%) |
| Sep 2005 | - | $37.23M(-8.2%) |
| Jun 2005 | - | $40.54M(-8.6%) |
| Mar 2005 | - | $44.33M(-11.8%) |
| Dec 2004 | $50.28M(+80.8%) | $50.28M(-8.8%) |
| Sep 2004 | - | $55.16M(-8.2%) |
| Jun 2004 | - | $60.10M(-8.1%) |
| Mar 2004 | - | $65.37M(+135.1%) |
| Dec 2003 | $27.81M(-36.6%) | $27.81M(-20.7%) |
| Mar 2003 | - | $35.09M(-20.0%) |
| Dec 2002 | $43.85M(-22.9%) | $43.85M(-14.1%) |
| Sep 2002 | - | $51.03M(-11.9%) |
| Jun 2002 | - | $57.96M(+15.5%) |
| Mar 2002 | - | $50.20M(-11.7%) |
| Dec 2001 | $56.84M(+3072.0%) | $56.84M(>+9900.0%) |
| Sep 2001 | - | $62.60K(-99.9%) |
| Jun 2001 | - | $67.23M(-6.5%) |
| Mar 2001 | - | $71.94M(+138.0%) |
| Sep 2000 | - | $30.23M |
| Dec 1997 | $1.79M | - |
FAQ
- What is Exact Sciences Corporation annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Exact Sciences Corporation?
- What is Exact Sciences Corporation annual cash & cash equivalents year-on-year change?
- What is Exact Sciences Corporation quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Exact Sciences Corporation?
- What is Exact Sciences Corporation quarterly cash & cash equivalents year-on-year change?
What is Exact Sciences Corporation annual cash & cash equivalents?
The current annual cash & cash equivalents of EXAS is $1.04B
What is the all time high annual cash & cash equivalents for Exact Sciences Corporation?
Exact Sciences Corporation all-time high annual cash & cash equivalents is $1.84B
What is Exact Sciences Corporation annual cash & cash equivalents year-on-year change?
Over the past year, EXAS annual cash & cash equivalents has changed by +$260.38M (+33.48%)
What is Exact Sciences Corporation quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of EXAS is $858.43M
What is the all time high quarterly cash & cash equivalents for Exact Sciences Corporation?
Exact Sciences Corporation all-time high quarterly cash & cash equivalents is $1.84B
What is Exact Sciences Corporation quarterly cash & cash equivalents year-on-year change?
Over the past year, EXAS quarterly cash & cash equivalents has changed by -$88.35M (-9.33%)